What is the appropriate management for a patient presenting with spiking fevers, abdominal pain, vomiting, and a Salmonella typhi O titer of 1:80?

Management of Suspected Typhoid Fever

Start empirical treatment immediately with intravenous ceftriaxone while awaiting blood culture confirmation, as the Widal test O titer of 1:80 is insufficient for diagnosis and fluoroquinolone resistance now exceeds 70% in most regions 1.

Diagnostic Considerations

Your patient's Widal test result is not diagnostic. The O titer of 1:80 falls below the diagnostic threshold:

• Diagnostic titers require ≥1:160 for both H and O antigens to be strongly suggestive of typhoid fever 2
• The Widal test lacks sensitivity and specificity and is not recommended by current guidelines 1
• Only 4% of healthy individuals and 8% of non-typhoid patients have titers ≥1:80, but this still creates too many false positives 2

Obtain blood cultures immediately - these have the highest yield within the first week of symptoms (40-80% sensitivity) and are the gold standard for diagnosis 1, 3. The clinical presentation of spiking fevers, abdominal pain, and vomiting is consistent with enteric fever, making empirical treatment justified while awaiting culture results.

First-Line Empirical Treatment

Intravenous ceftriaxone is now the preferred first-line agent for the following critical reasons 1:

• More than 70% of S. typhi and S. paratyphi isolates are fluoroquinolone-resistant, particularly from Asia 1
• All isolates reported in recent surveillance were sensitive to ceftriaxone 1
• Fluoroquinolone resistance testing with ciprofloxacin discs is unreliable - only nalidixic acid-sensitive isolates should be considered truly fluoroquinolone-sensitive 1

Alternative Oral Options (for uncomplicated disease once improving):

• Azithromycin: Suitable oral alternative with lower clinical failure rates than fluoroquinolones (OR 0.48) and lower relapse rates than ceftriaxone (OR 0.09) 4
• Azithromycin resistance remains rare currently 1
• Avoid cefixime as first-line: treatment failure rates of 4-37.6% have been reported 1

Treatment Algorithm Based on Resistance Patterns

If culture confirms fully sensitive S. typhi:

• Fluoroquinolones (ciprofloxacin, ofloxacin) remain most effective with fever clearance <4 days and cure rates >96% 1
• But verify nalidixic acid sensitivity on disc testing 1

If fluoroquinolone resistance confirmed:

• Continue ceftriaxone OR switch to azithromycin for oral therapy 4, 1

If multidrug-resistant (resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole):

• Fluoroquinolone if sensitive, otherwise ceftriaxone or azithromycin 4

Critical Pitfalls to Avoid

1. Do not delay treatment waiting for Widal confirmation - the clinical picture is decisive when titers are equivocal 2

2. Do not use fluoroquinolones empirically given >70% resistance rates 1

3. Monitor for complications (occur in 10-15% of patients, more likely if illness >2 weeks) 1:

   • Intestinal perforation/bleeding
   • Typhoid encephalopathy
   • Splenic complications (infarcts, abscesses) 5, 6
   • Hepatic involvement 6

4. Remember that prior typhoid vaccination provides incomplete protection and does not protect against paratyphoid 1

Monitoring Response

• Expect fever clearance within 3-4 days with appropriate therapy 1
• If clinical condition is unstable or deteriorating, maintain high suspicion for complications requiring imaging 5, 6
• Antibiotic treatment does not affect antibody rise, so repeat Widal testing is not useful for monitoring 2